kiau Biden raises $21.5 million but trails Buttigieg in fundraising
发表于 ： 2024年 12月 17日 13:14
Xpin Packed Cameroon train derails, killing at least 53 people
As of Friday, the Centers for Disease Control and stanley cup Prevention said there are 38 million doses of H1N1 vacc stanley cup ine available, far short of the 159 million needed to cover people who fall into the highest risk groups, su stanley cup ch as pregnant women and children.Bruce Gellin, director for the National Vaccine Program office at the U.S. Department of Health and Human Services, called the situation frustrating for both patients and local health departments trying to make and keep distribution plans.We know the vaccine is safe and effective and we wish we had more of it now, said Gellin. There is more coming, but it not coming as quickly as we would like.Gellin said manufacturers have continued to tinker with the efficiency of the production of the H1N1 vaccine, making improvements to the yield, but that global influenza vaccine capacity is largely fixed, due to the number of facilities and the time-tested, but time-intensive, process of growing vaccine virus in eggs.However, one tool for stretching vaccine supply, called adjuvants, has not been employed by the United States in this pandemic. Adjuvants are enhancers that help boost the immune response to a vaccine, allowing less antigen to be used for each dose and more doses to be distributed.Many countries in Europe, the Middle East and Asia, as well as Canada have primarily placed orders for adjuvanted versions of H1N1 vaccine, according to Marie-Paule Kieny, director of the Initiative for Va Pfth Follow NewsHour s Super Tuesday live blog
U.S. manufacturers of COVID-19 vaccines are seeking additional approvals from federal regulators in order to distribute and administer more booster shots for at-risk Americans and first doses for children ages 5 to 11.Watch the event in the player above. With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson Johnson vaccine wait anxiously to learn when it their turn.Federal regulators begin tackling that question this week.Jeffrey Zients, the White House COVID Response Coordinator, said the U.S. booster shot program is off to a very strong start and continues to accelerate.By the end of today, we estimate that over seven million Americans will have gotten their bo nike dunk oster shot, inclu stanley cup ding about three million just in the last week, jordan Zients said. And importantly, in less than three weeks, more than one in three eligible seniors have already gotten their third shot.On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra doses of the Moderna and JJ vaccines should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week.READ MORE: FDA now begins to look at approving Moderna and Johnson Johnson boostersAfter the FDA advisers give their recommendation, the agency itself
As of Friday, the Centers for Disease Control and stanley cup Prevention said there are 38 million doses of H1N1 vacc stanley cup ine available, far short of the 159 million needed to cover people who fall into the highest risk groups, su stanley cup ch as pregnant women and children.Bruce Gellin, director for the National Vaccine Program office at the U.S. Department of Health and Human Services, called the situation frustrating for both patients and local health departments trying to make and keep distribution plans.We know the vaccine is safe and effective and we wish we had more of it now, said Gellin. There is more coming, but it not coming as quickly as we would like.Gellin said manufacturers have continued to tinker with the efficiency of the production of the H1N1 vaccine, making improvements to the yield, but that global influenza vaccine capacity is largely fixed, due to the number of facilities and the time-tested, but time-intensive, process of growing vaccine virus in eggs.However, one tool for stretching vaccine supply, called adjuvants, has not been employed by the United States in this pandemic. Adjuvants are enhancers that help boost the immune response to a vaccine, allowing less antigen to be used for each dose and more doses to be distributed.Many countries in Europe, the Middle East and Asia, as well as Canada have primarily placed orders for adjuvanted versions of H1N1 vaccine, according to Marie-Paule Kieny, director of the Initiative for Va Pfth Follow NewsHour s Super Tuesday live blog
U.S. manufacturers of COVID-19 vaccines are seeking additional approvals from federal regulators in order to distribute and administer more booster shots for at-risk Americans and first doses for children ages 5 to 11.Watch the event in the player above. With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson Johnson vaccine wait anxiously to learn when it their turn.Federal regulators begin tackling that question this week.Jeffrey Zients, the White House COVID Response Coordinator, said the U.S. booster shot program is off to a very strong start and continues to accelerate.By the end of today, we estimate that over seven million Americans will have gotten their bo nike dunk oster shot, inclu stanley cup ding about three million just in the last week, jordan Zients said. And importantly, in less than three weeks, more than one in three eligible seniors have already gotten their third shot.On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra doses of the Moderna and JJ vaccines should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week.READ MORE: FDA now begins to look at approving Moderna and Johnson Johnson boostersAfter the FDA advisers give their recommendation, the agency itself